Abstract
Purpose
It is widely accepted that RPE melanin has a protective effect against oxidative damage in RPE cells. It is possible that an additional protective characteristic of melanin is the ability to modulate RPE cell immune response. In this study, in vitro modeling was used to probe the relationship between RPE pigmentation and immune response by monitoring IL-6 expression and secretion in calf melanin pigmented ARPE-19 cells seeded onto glycated extracellular matrix as a stressor.
Methods
ARPE-19 cells were left unpigmented or were pigmented with either calf melanin or latex beads, and were then seeded onto RPE-derived extracellular matrix (ECM) or tissue culture-treated plates (no ECM). ECMs were modified by glycation. IL-6 expression was measured using qPCR and IL-6 secretion was determined using an ELISA, both at 30 min and 24 h after seeding. MTT assay was used to quantify cell attachment to glycated matrices 30 min after seeding. In unpigmented ARPE-19 cells, rate of cell attachment to substrate was monitored for 60 min after seeding using a hemacytometer to count unattached cells. Additionally, cell viability was evaluated using the Neutral Red assay 24 h after seeding.
Results
A significant increase in IL-6 expression was observed in calf melanin pigmented cells versus latex bead and unpigmented controls (p < 0.0001) 30 min after seeding onto ECM. Twenty-four hours after seeding, a significant decrease in IL-6 expression was observed in calf melanin pigmented cells (p < 0.0001) versus controls, implicating down-regulation of the cytokine. Additionally, calf melanin pigmented cell populations showed significant increase in attachment compared to unpigmented controls on either no ECM or unmodified ECM.
Conclusions
Pigmentation of RPE cells with calf melanin resulted in significant changes in IL-6 expression regardless of ECM modification, in vitro. These findings suggest that melanin in the RPE may participate in immune response modulation in the retina with particular regard to cell attachment to protein substrates. The results of this study further implicate the role of chemical changes to melanin in regulating inflammation in retinal disease.
Similar content being viewed by others
References
Zinn K, Marmor M (1979) The retinal pigment epithelium. Harvard University Press, Cambridge
Zhou R, Caspi RR (2010) Ocular immune privilege. F1000 Biol Rep 2:1–3. https://doi.org/10.3410/B2-3
Detrick B, Hooks JJ (2010) Immune regulation in the retina. Immunol Res 47:153–161. https://doi.org/10.1007/s12026-009-8146-1
Curcio CA, Johnson M (2013) Structure, function, and pathology of Bruch’s membrane. In: Ryan SJ, Schachat AP, Wilkinson CP, Hinton DR, Sadda S, Wiedemann P (eds) Retina, Vol. 1, part 2: basic science and translation to therapy, 5th edn. Elsevier, London, pp 466–481
Sun K, Cai H, Tezel TH, Paik D, Gaillard ER, Del Priore LV (2007) Bruch’s membrane aging decreases phagocytosis of outer segments by retinal pigment epithelium. Mol Vis 13:2310–2319
Glenn JV, Mahaffy H, Wu K, Smith G, Nagai R, Simpson DA, Boulton ME, Stitt AW (2009) Advanced glycation end product (AGE) accumulation on Bruch’s membrane: links to age-related RPE dysfunction. Invest Ophthalmol Vis Sci 50:441–451. https://doi.org/10.1167/iovs.08-1724
Wang Z, Dillon J, Gaillard ER (2006) Antioxidant properties of melanin in retinal pigment epithelial cells. Photochem Photobiol 82:474–479. https://doi.org/10.1562/2005-10-21-RA-725
Seagle BL, Kourous AR, Yasuhiro K, Elzbieta GM, Kasra RA, Norris JR (2005) Melanin photoprotection in the human retinal pigment epithelium and its correlation with light-induced cell apoptosis. Proc Natl Acad Sci U S A 102:8978–8983. https://doi.org/10.1073/pnas.0501971102
Seagle BL, Gasyna EM, Mieler WF, Norris JR (2006) Photoprotection of human retinal pigment epithelium cells against blue light-induced apoptosis by melanin free radicals from Sepia officinalis. Proc Natl Acad Sci U S A 103:16644–16648. https://doi.org/10.1073/pnas.0605986103
Burke JM, Kaczara P, Skumatz CM, Zareba M, Raciti MW, Sarna T (2011) Dynamic analysis reveal cytoprotection by RPE melanosomes against non-photic stress. Mol Vis 17:2864–2877
Carr RE, Sigel IM (1979) The retinal pigment epithelium in ocular albinism. In: The retinal pigment epithelium. Harvard University Press, Cambridge, pp 413–423
Sarna T (1992) Properties and function of the ocular melanin—a photobiophysical view. J Photochem Photobiol B 12:215–258. https://doi.org/10.1016/1011-1344(92)85027-R
Smith-Thomas L, Richardson P, Thody AJ, Graham A, Palmer I, Flemming L, Parsons MA, Rennie IG, MacNeil S (1996) Human ocular melanocytes and retinal pigment epithelial cells differ in their melanogenic properties in vivo and in vitro. Curr Eye Res 15:1079–1091. https://doi.org/10.3109/02713689608995139
Sarna T, Burke JM, Korytowski W, Rozanowska M, Skumatz CM, Zareba A, Zareba M (2003) Loss of melanin from human RPE with aging: possible role of melanin photooxidation. Exp Eye Res 76:89–98. https://doi.org/10.1016/S0014-4835(02)00247-6
Zadlo A, Burke JM, Sarna T (2009) Effect of untreated and photobleached bovine RPE melanosomes on the photoinduced peroxidation of lipids. Photochem Photobiol Sci 8:830–837. https://doi.org/10.1039/b901820d
Zareba M, Szewczyk G, Sarna T, Hong L, Simon JD, Henry MM, Burke JM (2006) Effects of Photodegradation on the physical and antioxidant properties of melanosomes isolated from retinal pigment epithelium. Photochem Photobiol 82:1024–1029. https://doi.org/10.1562/2006-03-08-RA-836
Ito S, Kikuta M, Koike S, Szewczyk G, Sarna M, Zadlo A, Sarna T, Wakamatsu K (2016) Roles of reactive oxygen species in UVA-induced oxidation of 5,6-dihydroxyindole-2-carboxylic acid-melanin as studied by differential spectrophotometric method. Pigment Cell Melanoma Res 29:340–351. https://doi.org/10.1111/pcmr.12469
Ito S, Pilat A, Gerwat W, Skumatz CM, Ito M, Kiyono A, Zadlo A, Nakanishi Y, Kolbe L, Burke JM, Sarna T, Wakamatsu K (2013) Photoaging of human retinal pigment epithelium is accompanied by oxidative modifications of its eumelanin. Pigment Cell Melanoma Res 26:357–366. https://doi.org/10.1111/pcmr.12078
Polosa A, Bessaklia H, Lachapelle P (2017) Light-induced retinopathy: young age protects more than ocular pigmentation. Curr Eye Res 42:924–935. https://doi.org/10.1080/02713683.2016.1255336
Zareba M, Skumatz CM, Sarna TJ, Burke JM (2014) Photic injury to cultured RPE varies among individual cells in proportion to their endogenous lipofuscin content as modulated by their melanosome content. Invest Ophthalmol Vis Sci 55:4982–4990. https://doi.org/10.1167/iovs.14-14310
Elner VM, Scales W, Elner SG, Danforth J, Kunkel SL, Strieter RM (1992) Interleukin-6 (IL-6) gene expression and secretion by cytokine-stimulated human retinal pigment epithelial cells. Exp Eye Res 54:361–368. https://doi.org/10.1016/0014-4835(92)90048-W
Benson MT, Shepherd L, Rees RC, Rennie IG (1992) Production of interleukin-6 by human retinal pigment epithelium in vitro and its regulation by other cytokines. Curr Eye Res 11:173–179. https://doi.org/10.3109/02713689208999529
Nishida T, Nakamura M, Mishima H, Otori T (1992) Interleukin 6 promotes epithelial migration by a fibronectin-dependent mechanism. J Cell Physiol 153:1–5. https://doi.org/10.1002/jcp.1041530102
Jovanovic M, Vicovac L (2009) Interleukin-6 stimulates cell migration, invasion and integrin expression in HTR-8/SVneo cell line. Placenta 30:320–328. https://doi.org/10.1016/j.placenta.2009.01.013
Hsu C, Chung Y (2006) Influence of Interleukin-6 on the invasiveness of human colorectal carcinoma. Anticancer Res 26:4607–4614
Baynes JW (2001) The role of AGEs in aging: causation or correlation. Exp Gerontol 36:1527–1537. https://doi.org/10.1016/S0531-5565(01)00138-3
Thornalley PJ (1999) The clinical significance of glycation. Clin Lab 45:263–273
Basta G, Schmidt AM, De Caterina R (2004) Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 63:582–592. https://doi.org/10.1016/j.cardiores.2004.05.001
Monnier VM, Sell DR, Nagaraj RH, Miyata S, Grandhee S, Odetti P, Ibrahim SA (1992) Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes 41:36–41. https://doi.org/10.2337/diab.41.2.S36
Handa JT, Verzijl N, Matsunaga H, Aotaki-Keen A, Lutty GA, te Koppele JM, Miyata T, Hjelmeland LM (1999) Increase in the advanced glycation end product Pentosidine in Bruch’s membrane with age. Invest Ophthalmol Vis Sci 40:775–779
Ishibashi T, Murata T, Hangai M, Nagai R, Horiuchi S, Lopez PF, Hinton DR, Ryan SJ (1998) Advanced glycation end products in age-related macular degeneration. Arch Ophthalmol 116:1629–1632. https://doi.org/10.1001/archopht.116.12.1629
Howes KA, Liu Y, Dunaief JL, Miliam A, Frederick JM, Marks A, Baehr W (2004) Receptor for advanced glycation end products and age-related macular degeneration. Invest Ophthalmol Vis Sci 45:3713–3720. https://doi.org/10.1167/iovs.04-0404
Tian J, Ishibashi K, Ishibashi K, Reiser K, Grebe R, Biswal S, Gehlbach P, Handa JT (2005) Advanced glycation endproduct-induced aging of the retinal pigment epithelium and choroid: a comprehensive transcriptional response. Proc Natl Acad Sci U S A 102:11846–11851. https://doi.org/10.1073/pnas.0504759102
Ma W, Lee SE, Guo J, Qu W, Hudson BI, Schmidt AM, Barile GR (2007) RAGE ligand upregulation of VEGF secretion in ARPE-19 cells. Invest Opthalmol Vis Sci 48:1355–1361. https://doi.org/10.1167/iovs.06-0738
Fields MA, Cai H, Bowrey HE, Moreira EF, Gooz MB, Kunchithapautham K, Gong J, Vought E, Del Priore LV (2015) Nitrite modifications of extracellular matrix alters CD46 expression and VEGF release in human retinal pigment epithelium. Invest Ophthalmol Vis Sci 56:4231–4238. https://doi.org/10.1167/iovs.15-16438
Lopez VM, Decatur CL, Stamer DW, Lynch RM, McKay BS (2008) L-DOPA is an endogenous ligand for OA1. PLoS Biol 6:e236. https://doi.org/10.1371/journal.pbio.0060236
Brilliant MH, Vaziri K, Connor TB, Schwartz SG, Carroll JJ, McCarty CA, Schrodi SJ, Hebbring SJ, Kishor KS, Flynn HW, Moshfeghi AA, Moshfeghi DM, Fini EM, McKay BS (2016) Mining retrospective data for virtual prospective drug repurposing: L-DOPA and age-related macular degeneration. Am J Med 129:292–298. https://doi.org/10.1016/j.amjmed.2015.10.015
Murdaugh LS, Dillon J, Gaillard ER (2009) Modifications to the basement membrane protein laminin using glycolaldehyde and A2E: a model for aging in Bruch’s membrane. Exp Eye Res 89:187–192. https://doi.org/10.1016/j.exer.2009.03.021
Thao MT, Gaillard ER (2016) The glycation of fibronectin by glycolaldehyde and methylglyoxal as a model for aging in Bruch’s membrane. Amino Acids 48:1631–1639. https://doi.org/10.1007/s00726-016-2222-3
Poliakov E, Srunnikova NV, Jiang J, Martinez B, Parikh T, Lakkaraju A, Thomas C, Brooks BP, Redmond TM (2014) Multiple A2E treatments lead to melanization of rod outer segment-challenged ARPE-19 cells. Mol Vis 20:285–300
Hook JJ, Nagineni CN, Hooper LC, Hayashi K, Detrick B (2008) IFN-β provides immune-protection in the retina by inhibiting ICAM-1 and CXCL9 in retinal pigment epithelial cells. J Immunol 180:3789–3796. https://doi.org/10.4049/jimmunol.180.6.3789
Ikeda Y, Yonemitsu Y, Onimaru M, Nakano T, Miyazaki M, Kohno R, Nakagawa K, Ueno A, Sueishi K, Ishibashi T (2006) The regulation of vascular endothelial growth factors (VEGF-A, -C, and -D) expression in the retinal pigment epithelium. Exp Eye Res 83:1031–1040. https://doi.org/10.1016/j.exer.2006.05.007
Planck SR, Dang TT, Graves D, Tara D, Ansel JC, Rosenbaum JT (1992) Retinal pigment epithelial cells secrete interleukin-6 in response to interleukin-1. Invest Ophthalmol Vis Sci 33:78–82
Chong DY, Boehlke CS, Zheng Q, Zhang L, Han Y, Zacks DN (2008) Interleukin-6 as a photoreceptor neuroprotectant in an experimental model of retinal detachment. Invest Ophthalmol Vis Sci 49:3193–3200. https://doi.org/10.1167/iovs.07-1641
Leibinger M, Muller A, Gobrecht P, Diekmann H, Andreadaki A, Fischer D (2013) Interleukin-6 contribues to CNS axon regeneration upon inflammatory stimulation. Cell Death Dis 4:e609. https://doi.org/10.1038/cddis.2013.126
Edwards AO, Ritter R, Abel KJ, Manning A, Panhuysen C, Farrer LA (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308:421–423. https://doi.org/10.1126/science.1110189
Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, Spencer KL, Kwan SY (2005) Complement factor H variant increase the risk of age-related macular degeneration. Science 308:419–420. https://doi.org/10.1126/science.1110359
Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308:385–389. https://doi.org/10.1126/science.1109557
Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJ, Silvestri G, Russell SR, Klaver CC, Barbazetto I, Chang S, Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK, Bergeron J, Zernant J, Merriam JE, Gold B, Dean M, Allikmets R (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102:7227–7232. https://doi.org/10.1073/pnas.0501536102
Hageman GS, Mullins RF (1999) Molecular composition of drusen as related to substructural phenotype. Mol Vis 5:28
Anderson DH, Mullins RF, Hageman GS, Johnson LV (2002) A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134:411–431. https://doi.org/10.1016/S0002-9394(02)01624-0
Jonas JB, Tao Y, Neumaier M, Findeisen P (2012) Cytokine concentrations in aqueous humour of eyes with exudative age-related macular degeneration. Acta Ophthalmol 90:e381–e388. https://doi.org/10.1111/j.1755-3768.2012.02414.x
Schraermeyer U, Koptiz J, Peters S, Henke-Fahle S, Blitgen-Heinecke P, Kokkinou D, Schwarz T, Bartz-Schmidt K (2006) Tyrosinase biosynthesis in adult mammalian retinal pigment epithelial cells. Exp Eye Res 83:315–321. https://doi.org/10.1016/j.exer.2005.12.015
Julien S, Kociok N, Kreppel F, Koptiz J, Kochanek S, Biesemeier A, Blitgen-Heineck P, Heiduschka P, Schraermeyer U (2007) Tyrosinase biosynthesis and trafficking in adult human retinal pigment epithelial cells. Graefes Arch Clin Exp Ophthalmol 245:1495–1505. https://doi.org/10.1007/s00417-007-0543-3
Aruta C, Giordano F, De Marzo A, Comitato A, Raposo G, Nandrot EF, Marigo V (2010) In vitro differentiation of retinal pigment epithelium from adult retinal stem cells. Pigment Cell Melanoma Res 24:233–240. https://doi.org/10.1111/j.1755-148X.2010.00793.x
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with human participants performed by any of the authors.
Electronic supplementary material
ESM 1
(PDF 809 kb)
Rights and permissions
About this article
Cite this article
Yacout, S.M., Elsawa, S.F. & Gaillard, E.R. Calf melanin immunomodulates RPE cell attachment to extracellular matrix protein. Graefes Arch Clin Exp Ophthalmol 256, 1883–1893 (2018). https://doi.org/10.1007/s00417-018-4083-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-018-4083-9